Tristel
TSTL · AIM · Health Care · mcap £199m · 432.5p
Directors
award Tristel plc announced on 24 November 2025 the grant of 181,972 new share options under its Long Term Incentive Plan to two directors: CEO Matt Sassone received 106,479 options, increasing his aggregate to 183,483, and CF 24 Nov 2025
purchase Tristel plc announced that Non-Executive Director Tom Jenkins purchased 5,400 ordinary shares at 368 pence per share on December 11, 2025, increasing his beneficial interest to 13,400 shares, representing 0.03% of the to 12 Dec 2025
other Tristel plc reported a positive first half with revenues up 14% year-on-year, maintaining gross margins at 81% and increasing adjusted EBITDA by 17% to 28% margins, exceeding their 25% target. The company remains debt-fr 22 Jan 2026
purchase Tristel plc announced that Non-Executive Director Caroline Stephens purchased 2,597 ordinary shares at 382.47 pence per share on March 20, 2026. Following this transaction, her beneficial interest in the company, includi 23 Mar 2026
Company filings. Not investment advice.